Propranolol: Clinical Trials

43 trials of Propranolol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 completed, 8 terminated, 6 recruiting, 3 unknown. 43 Phase 1, 11 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 143Completed 19, Terminated 8, Recruiting 6, Unknown 3, Suspended 2, Withdrawn 2, Active not recruiting 1, Enrolling by invitation 1, Not yet recruiting 1
Phase 211Suspended 2, Terminated 2, Unknown 2, Active not recruiting 1, Completed 1, Not yet recruiting 1, Recruiting 1, Withdrawn 1

Follow Propranolol: new trials by email Literature Review of Propranolol trials Research Report on Propranolol

Trials (filtered) newest first · largest first

All 43 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neoadjuvant Propranolol Plus SOX and Toripalimab for Locally Advanced Gastric/GEJ Adenocarcinoma
propranolol, Toripalimab, Oxaliplatin - Gastric or Gastroesophageal Junction Adenocarcinoma, Propranolol
Phase 1 / Phase 2Not yet recruitingTing Liu492026-08-012026-07-27
Propranolol Hydrochloride Combined With Toripalimab and Platinum-based Chemotherapy in Resectable Non-Small Cell Lung Cancer
Propranolol Hydrochloride, Toripalimab, Chemotherapy - Resectable Non-Small-Cell Lung Cancer
Phase 1RecruitingSecond Xiangya Hospital of Central South University92026-06-012026-10-21
Propranolol Hydrochloride Combined With Adebrelimab and Platinum-Based Chemotherapy in Small Cell Lung Cancer
Propranolol Hydrochloride, Adebrelimab, Chemotherapy - Small Cell Lung Cancer (SCLC)
Phase 1RecruitingSecond Xiangya Hospital of Central South University182026-05-292026-10-21
Propranolol Plus Standard Radiation Therapy Before Surgery for the Treatment of Patients With Soft Tissue Sarcoma
Biopsy, Biospecimen Collection, Computed Tomography - Soft Tissue Sarcoma
Phase 1WithdrawnRoswell Park Cancer Institute2026-05-152025-08-26
Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC
propranolol, Tislelizumab, gemcitabine - Bladder Urothelial Carcinoma, Lymph Node Metastasis
Phase 1Enrolling by invitationSun Yat-Sen Memorial Hospital of Sun Yat-Sen University122026-01-012026-04-22
Propranolol Treatment for Postoperative Chylothorax
Propranolol Hydrochloride, Placebo - Postoperative Chylothorax, Congenital Heart Disease
Phase 1 / Phase 2SuspendedJune Wu502025-09-092026-05-15
Evaluating the Impact of Adjuvant Use of Beta Blockers on Clinical Outcomes in Patients With Traumatic Brain Injury
control, propranolol, Carvedilol - TBI Traumatic Brain Injury
Phase 1 / Phase 2RecruitingMansoura University1002025-01-202025-04-02
Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer
Propranolol hydrochloride, Sintilimab, Chemotherapy - Non Small Cell Lung Cancer, Propranolol
Phase 1RecruitingSecond Xiangya Hospital of Central South University62024-11-132024-11-19
Naltrexone and Propranolol Combined With Immunotherapy
Propranolol, Naltrexone - Advanced Melanoma
Phase 1RecruitingSarah Weiss122023-09-112025-09-18
Beta-blocker Administration for Cardiomyocyte Division
N-thymidine, Urine Collection, Echocardiogram - Tetralogy of Fallot, Double Outlet Right Ventricle
Phase 1RecruitingWeill Medical College of Cornell University402022-12-162026-10-26
A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Sertraline
Propranolol, Prazosin - Post-traumatic Stress Disorder (PTSD)
Phase 1TerminatedOtsuka Pharmaceutical Development & Commercialization, Inc.342022-09-072024-01-23
Propranolol for Protracted Labor
Propranolol - Labour;Obstructed, Labor Dystocia
Phase 1CompletedChristiana Care Health Services802021-07-272022-07-28
A Study of Ponesimod in Healthy Adult Participants Receiving Propranolol at Steady State
Ponesimod dose range (2 - 20 mg), Placebo Propranolol, Propranolol 80 mg - Healthy
Phase 1CompletedJanssen Pharmaceutica N.V., Belgium522019-03-202025-04-27
Efficacy Evaluation of Propranolol Treatment of Hepatic Hemangioma
Propranolol Hydrochloride - Hemangioma Liver
Phase 1 / Phase 2TerminatedSecond Affiliated Hospital, Zhejiang University, School of Medicine82018-07-012025-05-22
Oral Propanolol for Surgically Inaccessible Cavernous Malformations
Propranolol Oral Tablet, Placebo Oral Tablet - Cavernous Malformations,Cerebral and/or Spinal
Phase 1UnknownUniversity of Virginia3462018-02-072018-05-14
Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery
Laboratory Biomarker Analysis, Pembrolizumab, Propranolol Hydrochloride - Stage IIIC Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7
Phase 1 / Phase 2SuspendedRoswell Park Cancer Institute472018-01-312026-07-15
Brief Stresses Experimental Study
Propranolol, Placebo oral capsule, Acute stress task - DNA Damage, Psychological Stress
Phase 1TerminatedDana Bovbjerg2392017-10-052023-07-18
A Study of Lasmiditan and Propranolol in Healthy Participants
Lasmiditan, Propranolol - Healthy
Phase 1CompletedEli Lilly and Company442017-08-312019-12-16
Propranolol for Treating Fibromyalgia Pain
Propranolol 1, Propranolol 2, Placebo - Fibromyalgia Pain
Phase 1TerminatedUniversity of Utah152017-01-012018-08-23
Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A Collaborative and Innovative Phase I-II Sequential Trial by the French Sarcoma Group (GSF/GETO)
PROPRANOLOL - Angiosarcoma
Phase 1 / Phase 2UnknownAssistance Publique Hopitaux De Marseille242016-05-012016-04-11

Showing 20 of 43. Sign in to see all of them.

Conditions studied

Brain Injuries, Traumatic (2)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Depressive Disorder, Major (2)  ·  Melanoma (2)  ·  Pulmonary Disease, Chronic Obstructive (2)  ·  Stress Disorders, Post-Traumatic (2)  ·  Stress, Psychological (2)  ·  Anemia, Sickle Cell (1)  ·  Arteriosclerosis (1)  ·  Autonomic Nervous System Diseases (1)  ·  Brain Injuries (1)  ·  Chylothorax (1)  ·  Cocaine-Related Disorders (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)

Sponsors

Second Xiangya Hospital of Central South University (3)  ·  Actavis Inc. (2)  ·  Boehringer Ingelheim (2)  ·  Eli Lilly and Company (2)  ·  Roswell Park Cancer Institute (2)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  Astellas Pharma Inc (1)  ·  Christiana Care Health Services (1)  ·  Dana Bovbjerg (1)  ·  GlaxoSmithKline (1)  ·  Janssen Pharmaceutica N.V., Belgium (1)  ·  Johns Hopkins University (1)  ·  June Wu (1)  ·  Mansoura University (1)  ·  Merck Sharp & Dohme LLC (1)

Countries

United States (24)  ·  China (5)  ·  France (2)  ·  United Kingdom (2)  ·  Belgium (1)  ·  Egypt (1)  ·  Germany (1)  ·  Israel (1)  ·  Switzerland (1)

Top investigators

James D. Carlson,, Pharm.D, (2)  ·  Akiko Okifuji, PhD (1)  ·  Anurag K Singh (1)  ·  Bernhard Kuhn, MD (1)  ·  Dana Bovbjerg, PhD (1)  ·  Frank Jenkins, PhD (1)  ·  Helen B Gomez, MD (1)  ·  Joachim E Fischer, MD, MSc (1)  ·  June Wu, MD (1)  ·  Kenzie Preston, Ph.D. (1)  ·  Leslie Z Benet, PhD (1)  ·  Lynda Frassetto, MD (1)

Results publications

PMID 15583741, PMID 15890495, PMID 15911704, PMID 15978266, PMID 18550886, PMID 19687359, PMID 19840322, PMID 20117846, PMID 20644039, PMID 20732454, PMID 20797926, PMID 20936416, PMID 24002370, PMID 24227635, PMID 24495468, PMID 24606242, PMID 24721800, PMID 32673517, PMID 34265312

NIH funding

2015 (1), 2018 (1), R01CA211371 (1), R01HL155597 (1), U54DA037842 (1), UL1TR000445 (1)